{"id":"W3007541271","doi":"10.1016/j.ejca.2020.01.007","title":"European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention","year":2020,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Instituto Superior de Agronomia; Merck Sharp and Dohme; Sandoz; Bristol-Myers Squibb Canada; Genentech; Sun Pharma; Genesis Pharma; Eisai; SkylineDx; Pfizer; Biogen; Incyte; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Mylan; Galderma; UCB; AbbVie; Health Research; Novartis; Celgene; LEO Pharma; Bayer; Wyeth; Agence Nationale de la Recherche; Roche; Sanofi; Merck; Amgen; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Guideline; Epidemiology; Medicine; Basal cell; Dermatology; Oncology; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001090134,0.0001701194,0.0004616238,0.00004906287,0.00007434258,0.000005204784,0.0002206349,0.00001782966,0.00006860183],"category_scores_gemma":[0.001231599,0.0001078906,0.0001945794,0.0001166881,0.0002023459,0.00004488059,0.0004021873,0.0003862052,0.00001041713],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006233712,"about_ca_system_score_gemma":0.0001088723,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003486666,"about_ca_topic_score_gemma":0.00000793605,"domain_scores_codex":[0.9975153,0.0009485409,0.0009564435,0.0001913893,0.0002174848,0.0001708848],"domain_scores_gemma":[0.9980289,0.0004050313,0.0009345339,0.0002106483,0.0002556542,0.0001651788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001546258,0.0002390826,0.4915882,0.000499207,0.0002807885,0.001150594,0.006715632,0.0005854922,0.001369119,0.00003924984,0.4391683,0.05681812],"study_design_scores_gemma":[0.002963706,0.003763928,0.9416781,0.0007465651,0.0003881851,0.0001416136,0.0006809816,0.00002100259,0.004384547,0.00006226807,0.04501544,0.0001536461],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9282904,0.0192052,0.0003217097,0.03131709,0.0008944783,0.0003016769,0.00002864193,0.000008712818,0.01963211],"genre_scores_gemma":[0.9928238,0.001418798,0.0005092874,0.003273098,0.001686533,0.000001255299,0.000001721231,0.0000438074,0.0002416405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.45009,"threshold_uncertainty_score":0.439965,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0533766450898083,"score_gpt":0.3284284051082279,"score_spread":0.2750517600184196,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}